EPIRUS Biopharmaceuticals, Inc. (EPRS)

You are trying to access subscriber-only content.

If you are a subscriber, log in here.

If you are not a subscriber, click here for your subscription. Subscribers will have unlimited access to our magazine articles and more!

Article Excerpt

Insider buying is spurring momentum in these two biotech companies. One is a “buy now”, and the other is a “buy on a pullback.”

EPIRUS Biopharmaceuticals, Inc. (EPRS)
from Cotton’s Technically Speaking

On February 4, 2015, EPIRUS Biopharmaceuticals, Inc. (EPRS) insiders Scott Rocklage, and 5AM Partners III, LLC bought 400,000 shares of their…


You must be logged in to post a comment.